We are live on
!
Find out more
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
89 hedge funds and large institutions have $4.12M invested in Synergy Pharmaceuticals, Inc Common Stock in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 39 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
34% less funds holding
Funds holding: 134 → 89 (-45)
41% less call options, than puts
Call options by funds: $141K | Put options by funds: $239K
59% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 39
77% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 57
97% less capital invested
Capital invested by funds: $164M → $4.12M (-$160M)
Holders
89
Holders Change
-45
Holders Change %
-33.58%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
16
Reduced
39
Closed
57
Calls
$141K
Puts
$239K
Net Calls
-$98K
Net Calls Change
+$1.89M
Top Buyers
| 1 |
JG
Jefferies Group
New York
|
+$1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$335K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$317K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$173K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$171K |
Top Sellers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$14M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.4M |
| 3 |
BlackRock
New York
|
-$6.7M |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.66M |
| 5 |
HP
Hikari Power
Tokyo,
Japan
|
-$4.25M |
